# To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO

> **NCT05963594** · NA · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 44 (actual)

## Conditions studied

- Dietary Supplement

## Interventions

- **DIETARY_SUPPLEMENT:** Oligomalt
- **DIETARY_SUPPLEMENT:** maltodextrin

## Key facts

- **NCT ID:** NCT05963594
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-23
- **Primary completion:** 2023-03-28
- **Final completion:** 2023-03-28
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05963594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05963594, "To Evaluate the Post-Prandial Metabolic Effects of Oligomalt in Adults With T2D and in HAO". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05963594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*